We are live on ! Find out more
N

Nuveen Portfolio holdings

AUM $369B
1-Year Est. Return 31.66%
This Fund
S&P 500
This Quarter Est. Return
+10%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$264B
AUM Growth
+$16.6B
Cap. Flow
-$3.28B
Cap. Flow %
-1.24%
Top 10 Hldgs %
18.75%
Holding
3,331
New
118
Increased
1,090
Reduced
1,840
Closed
95

Top Sells

Rank Stock Value
1
CSCO icon
Cisco
CSCO
+$474M
2
CELG
Celgene Corp
CELG
+$421M
3
AVGO icon
Broadcom
AVGO
+$411M
4
NFLX icon
Netflix
NFLX
+$387M
5
AAPL icon
Apple
AAPL
+$372M

Sector Composition

Rank Sector Weight
1 Technology 20.51%
2 Financials 14.64%
3 Healthcare 13.3%
4 Consumer Discretionary 10.29%
5 Communication Services 9.4%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PMT
1751
PennyMac Mortgage Investment
PMT
$842M
$7.58M ﹤0.01%
340,232
-195,450
-36% -$4.42M
EDIT icon
1752
Editas Medicine
EDIT
$442M
$7.55M ﹤0.01%
254,965
+46,171
+22% +$1.15M
TCBI icon
1753
Texas Capital Bancshares
TCBI
$4.32B
$7.55M ﹤0.01%
132,979
-9,525
-7% -$543K
MC icon
1754
Moelis & Co
MC
$4.94B
$7.49M ﹤0.01%
234,667
+47,395
+25% +$1.55M
BYND icon
1755
Beyond Meat
BYND
$277M
$7.47M ﹤0.01%
98,787
+67,503
+216% +$6.26M
RDFN
1756
DELISTED
Redfin
RDFN
$7.46M ﹤0.01%
353,113
-3,308
-0.9% -$63.3K
TCBK icon
1757
TriCo Bancshares
TCBK
$1.83B
$7.46M ﹤0.01%
182,653
-4,019
-2% -$153K
ACHC icon
1758
Acadia Healthcare
ACHC
$2.94B
$7.44M ﹤0.01%
223,997
-13,694
-6% -$429K
QCRH icon
1759
QCR Holdings
QCRH
$1.7B
$7.44M ﹤0.01%
169,625
+17,571
+12% +$718K
NSTG
1760
DELISTED
NanoString Technologies, Inc.
NSTG
$7.42M ﹤0.01%
266,877
+10,424
+4% +$253K
CMO
1761
DELISTED
Capstead Mortgage Corp.
CMO
$7.42M ﹤0.01%
937,141
+207,410
+28% +$1.6M
ADEA icon
1762
Adeia
ADEA
$3.11B
$7.41M ﹤0.01%
1,514,926
-99,263
-6% -$527K
MATX icon
1763
Matsons
MATX
$6.18B
$7.39M ﹤0.01%
181,230
-3,595
-2% -$137K
EPC icon
1764
Edgewell Personal Care
EPC
$1.31B
$7.37M ﹤0.01%
238,132
+8,562
+4% +$276K
AGS
1765
DELISTED
PlayAGS
AGS
$7.37M ﹤0.01%
607,726
+29,488
+5% +$337K
ATRO icon
1766
Astronics
ATRO
$3.84B
$7.35M ﹤0.01%
315,491
-103,119
-25% -$2.53M
SPTN
1767
DELISTED
SpartanNash
SPTN
$7.34M ﹤0.01%
515,457
+23,253
+5% +$307K
TILE icon
1768
Interface
TILE
$2.22B
$7.33M ﹤0.01%
441,879
+171,480
+63% +$2.76M
NKTR icon
1769
Nektar Therapeutics
NKTR
$2.58B
$7.32M ﹤0.01%
22,593
-13,230
-37% -$3.84M
AGYS icon
1770
Agilysys
AGYS
$3.06B
$7.31M ﹤0.01%
287,544
+27,721
+11% +$701K
HLI icon
1771
Houlihan Lokey
HLI
$9.02B
$7.31M ﹤0.01%
149,509
-2,284
-2% -$108K
PI icon
1772
Impinj
PI
$5.6B
$7.31M ﹤0.01%
282,545
-6,003
-2% -$187K
YETI icon
1773
Yeti Holdings
YETI
$3.95B
$7.29M ﹤0.01%
209,514
-214,123
-51% -$6.75M
NTCT icon
1774
NETSCOUT
NTCT
$2.79B
$7.28M ﹤0.01%
302,541
-5,393
-2% -$127K
CFFN icon
1775
Capitol Federal Financial
CFFN
$1.1B
$7.28M ﹤0.01%
530,002
-2,096
-0.4% -$29.5K

Similar funds

Nuveen's Q4 2019 Portfolio in Review

As of Q4 2019, Nuveen held 3,331 positions worth $264B, up 6.7% from $247B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Nuveen's Q4 2019 filing shows 118 new, 1,090 increased, 1,840 reduced and 95 closed positions. Its largest new stake was iShares iBoxx $ Investment Grade Corporate Bond ETF: 8,077,161 shares worth $1.03B. The largest sale was Cisco, an estimated $474M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Financials and Healthcare.

  • Nuveen's largest Q4 2019 buy was iShares iBoxx $ Investment Grade Corporate Bond ETF: 8,077,161 shares worth $1.03B.
  • Nuveen added most to Bristol-Myers Squibb in Q4 2019, an estimated $649M increase.
  • Nuveen's biggest Q4 2019 reduction was Cisco, cutting an estimated $474M.
  • Nuveen fully exited Celgene Corp in Q4 2019, selling an estimated $421M.
  • Nuveen's ten largest holdings make up 19% of its $264B portfolio in Q4 2019.
  • Nuveen opened 118 new positions and closed 95 in Q4 2019.
  • Nuveen's portfolio value rose 6.7% quarter-over-quarter to $264B.

Based on Nuveen's 13F filing for Q4 2019, filed 14 Feb 2020.